The Reality and Costs of Gene Therapy for Eye Disease: Who Will (or Can) Pay?

As our readers know, VisionAware is committed to providing current and reliable information about eye and vision research that is relevant to adults and older adults, many of whom experience late-life vision loss resulting in low vision. During the past several years, gene therapy has gained traction and offers promise for treating (but not yet … Continued

Researchers Continue to Explore the Potential of Human Echolocation and Acoustics for People with Vision Loss

Vision rehabilitation professionals, including Orientation and Mobility Specialists, Vision Rehabilitation Therapists, and Low Vision Therapists, have long been aware of the need to incorporate sensory input, including echolocation, in their instructional programs. Human echolocation describes the ability of humans to detect objects in their environments by sensing reflected sound waves from those objects. Now it … Continued

New Genetic Research in Diabetes Identifies a Protein That May Stop or Reduce Abnormal Blood Vessel Growth in the Retina

New genetic research in diabetes, led by a team from Harvard Medical School, has identified a potential new therapy targeting RUNX1 (explained below) that significantly reduced abnormal blood vessel growth in the retina, which is a hallmark of advanced diabetic eye disease. Although the research has been conducted only with “in vitro” (explained below) laboratory … Continued

May Is Healthy Vision Month: Make Your Eye Health a Priority and Learn How to Protect Your Vision

May is Healthy Vision Month, a national eye health observance established by the National Eye Institute (NEI) in May 2003. NEI is part of the National Institutes of Health, an agency of the United States Department of Health and Human Services. This year, NEI is encouraging women to make eye health a priority and has … Continued

The FDA Approves Lucentis for the Treatment of Diabetic Retinopathy

On April 17, 2017, the United States Food and Drug Administration (FDA) granted approval to the injectable drug Lucentis (generic name ranibizumab) for the treatment of proliferative diabetic retinopathy (PDR), a serious vision-related complication of diabetes. Previously, the FDA approved Lucentis for the treatment of diabetic macular edema (DME), a buildup of fluid in the … Continued

Do the Brains of Blind Persons “Rewire” or Adjust to Significantly Enhance the Other Senses? New Research Says Yes

An age-old question that surfaces regularly in my work is this one: “Is it true that blind people develop super senses, like extra-sensitive hearing or touch, to compensate for not being able to see?” A variation of the “super senses” question asks this: “Are the other senses truly enhanced, or do people without the sense … Continued

Are You at Risk for Type 2 Diabetes? Take the Test!

Editor’s note: Audrey Demmitt, VisionAware peer advisor and R.N., reminds everyone of the risk of diabetes and what you should know. Could you be the one in three American adults who is at risk for developing type 2 diabetes? Diabetes is a leading cause of blindness among working age adults, and that’s why VisionAware is … Continued

Understanding Our Shifting Health Insurance Landscape – and What It Means for People with Vision Loss

Guest blogger Rebecca Sheffield, Ph.D., is the Senior Policy Researcher with the American Foundation for the Blind (AFB) Public Policy Center in Washington, D.C. The AFB Public Policy Center collaborates with policy makers in Congress and the Executive Branch to ensure that Americans with vision loss have equal rights and opportunities to fully participate in … Continued

Understanding Our Shifting Health Insurance Landscape – and What It Means for People with Vision Loss

Guest blogger Rebecca Sheffield, Ph.D., is the Senior Policy Researcher with the American Foundation for the Blind (AFB) Public Policy Center in Washington, D.C. The AFB Public Policy Center collaborates with policy makers in Congress and the Executive Branch to ensure that Americans with vision loss have equal rights and opportunities to fully participate in … Continued

What Is It Like to Have Low Vision? A New Sight Simulator Can Help You Understand

A query I receive frequently from readers is how to describe their low vision or vision loss to fully sighted family members and friends, who may find it difficult to understand how functional vision can vary significantly from one day to the next, or from daytime to nighttime. While some basic explanations do exist (cataracts … Continued